Patents by Inventor Nicholas Backes

Nicholas Backes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • L-DOPA MICROBIOME THERAPY
    Publication number: 20230255915
    Abstract: The present invention generally provides methods and compositions for the treatment of Parkinson’s disease and depression and/or anxiety. The invention relates to recombinant microorganisms, particularly gut-colonizing probiotics, modified to produce L-DOPA.
    Type: Application
    Filed: January 12, 2023
    Publication date: August 17, 2023
    Inventors: Anumantha G. Kanthasamy, Ahmed Abdalla, Gregory Phillips, Nicholas Backes, Andrew D. Ellington, Ross Thyer
  • L-DOPA microbiome therapy
    Patent number: 11576883
    Abstract: The present invention generally provides methods and compositions for the treatment of Parkinson's disease and depression and/or anxiety. The invention relates to recombinant microorganisms, particularly gut-colonizing probiotics, modified to produce L-DOPA.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: February 14, 2023
    Assignees: Iowa State University Research Foundation, Inc., Board of Regents, The University of Texas System
    Inventors: Anumantha G. Kanthasamy, Ahmed Abdalla, Gregory Phillips, Nicholas Backes, Andrew D. Ellington, Ross Thyer
  • L-DOPA MICROBIOME THERAPY
    Publication number: 20190262298
    Abstract: The present invention generally provides methods and compositions for the treatment of Parkinson's disease and depression and/or anxiety. The invention relates to recombinant microorganisms, particularly gut-colonizing probiotics, modified to produce L-DOPA.
    Type: Application
    Filed: February 27, 2019
    Publication date: August 29, 2019
    Inventors: Anumantha G. Kanthasamy, Ahmed Abdalla, Gregory Phillips, Nicholas Backes